akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 107 blog entries.

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy National Patient Safety Alert Reference Number: NatPSA/2025/006/NHSPS Date issued: 20 November 2025 Explanation of identified safety issue There are reports of healthcare staff recording a patient’s penicillin allergy as a penicillamine allergy in electronic prescribing systems. This look-alike sound-alike [...]

The post National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy appeared first on Community Pharmacy England.

By |November 20th, 2025|Lexpos News|Comments Off on National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy

Funding & Reimbursement Shorts: Referred back items

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on referred back (or unpaid) items. With referred back items, pharmacy owners risk having their payments tied up until the required endorsement information is submitted to the NHS Business Services Authority (NHSBSA). Therefore, [...]

The post Funding & Reimbursement Shorts: Referred back items appeared first on Community Pharmacy England.

By |November 17th, 2025|Lexpos News|Comments Off on Funding & Reimbursement Shorts: Referred back items

MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited)

MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/48 Date issued: 11 November 2025 Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies. DMRC reference number: DMRC [...]

The post MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) appeared first on Community Pharmacy England.

By |November 11th, 2025|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited)

MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA)

MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA) Drug Alert Number: EL(25)A/47 Date issued: 10 November 2025 Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing. DMRC reference number: DMRC – 35367036 Marketing Authorisation Holder: Zambon SpA Medicine [...]

The post MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA) appeared first on Community Pharmacy England.

By |November 10th, 2025|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA)

Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules – Updated

Update 05/03/2026:  Propranolol 80mg modified release capsules are out of stock until July 2026 Propranolol 160mg modified release capsules are out of stock until July 2026 The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Propranolol 80mg modified release capsules Propranolol 160mg modified release capsules MSN/2025/059 [...]

The post Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules – Updated appeared first on Community Pharmacy England.

By |November 10th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules – Updated